News

March 18, 2016March 23, 2016

Study Finds IPF Patients Should Continue Pirfenidone Use Even as Disease Progresses

An international group of researchers addressed an important clinical question about idiopathic pulmonary fibrosis (IPF) — Should people with IPF continue treatment with pirfenidone (Esbriet) if their disease meaningfully worsens? ... Read more

March 16, 2016March 16, 2016

Viral Infections May Affect Cystic Fibrosis Patients’ Respiratory Microbiome, Study Says

Cystic Fibrosis, News

Viral infections in patients with cystic fibrosis (CF) have been linked to pulmonary exacerbations, according to the results of a study recently presented at the American Academy of Allergy, Asthma & ... Read more

March 16, 2016March 16, 2016

People with Severe Asthma Are Focus of Study to Better Target Treatment of XolairR

Asthma, News

A new study developed by researchers at the National Institute for Health Research (NIHR) Southampton Respiratory Biomedical Research Unit in England and managed by the NIHR-funded Clinical Trials Unit at the University of ... Read more

March 16, 2016May 13, 2016

Large-scale NAVIGATE Lung Cancer Trial Enrolls First Patients in Europe, Medtronic Announces

Lung Cancer, News

Medtronic recently announced it has enrolled its first European patients in its NAVIGATE clinical trial. The international trial will enroll a total of 2,500 patients to assessment the long-term outcomes of the company’s superDimension ... Read more

March 15, 2016March 16, 2016

For Previously Treated Non-Small-Cell Lung Cancer, Atezolizumab Seems to Be More Effective than Docetaxel, Report Shows

Lung Cancer, News

A recent Phase 2 clinical trial demonstrated that the cancer treatment atezolizumab was more effective compared to docetaxel at improving survival in patients with previously treated non-small-cell lung cancer (NSCLC). The research ... Read more

March 15, 2016May 13, 2016

New Gene Study to Determine Why Some People Are More Prone to Developing Asthma

Asthma, News

New research from the University of Southampton in England is set to expand scientists’ knowledge about why some people are more prone to develop asthma by analyzing a gene called ADAM33 – typically ... Read more

March 15, 2016March 16, 2016

For IPF Patients, Results Appear Promising in Phase 2 Study from FibroGen’s Investigative Drug

Idiopathic Pulmonary Fibrosis, News

FibroGen recently announced the publication of results from a Phase 2 clinical trial (NCT01262001) in patients with idiopathic pulmonary fibrosis (IPF), testing a 48-week treatment with the company’s investigational drug FG-3019, ... Read more

March 14, 2016May 13, 2016

Nit1 Gene May Contribute to Lung Cancer Development, Study Suggests

Lung Cancer, News

Recent research suggested that a “conserved” gene called Nitrilase 1 (Nit1) might contribute to lung cancer development. The findings were published in the journal Oncotarget under the title “Nitrilase 1 modulates ... Read more

March 14, 2016March 14, 2016

Greater Risk for COPD, Other Diseases Found with High Coronary Artery Calcium Scores, Study Shows

COPD, Lung Cancer, News, Pneumonia

People with a high coronary artery calcium (CAC) score puts them at increased risk not only for heart and vascular disease, but also for chronic obstructive pulmonary disease (COPD), cancer, and chronic ... Read more

March 14, 2016March 16, 2016

RespirTech Introduces Cystic Fibrosis Treatment Remote Monitoring System

Bronchiectasis, COPD, Cystic Fibrosis, News

RespirTech, an important provider of airway clearance therapy vests, is developing an innovative way for clinicians to remotely monitor the treatment of cystic fibrosis (CF) patients, funded by a Small Business Innovation Research (SBIR) ... Read more